Perbedaan Erajaya Swasembada Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Erajaya Swasembada Tbk. diperdagangkan di Rp456 (kapitalisasi pasar 7,27 T, volume 24 jam 91,25 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Erajaya Swasembada Tbk. jauh lebih besar — sekitar 44,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Erajaya Swasembada Tbk. lebih aktif diperdagangkan (91,25 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ERAA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 7,27 T | 164,65 M |
Volume | 91,25 jt | 187,4 rb |
Lot | 912,49 rb | 1,87 rb |
Perputaran | 42,38 M | 44,35 jt |
Harga Rata-rata | 464,46 | 236,67 |
Nilai Transaksi | 42,38 M | 44,35 jt |
Harga Ekuilibrium Indikatif | 456 | 242 |
Volume Ekuilibrium Indikatif | 26 rb | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Erajaya Swasembada Tbk (the Company) was established in Jakarta based on Notarial Deed No.7 of Myra Yuwono, S.H., dated October 8, 1996. Erajaya Group is the official distributor for 10 international mobile communication brands and an authorised partner for major mobile operators. Recently, the Group has launched its own mobile handset under the name of Venera. In 1996, PT Erajaya Swasembada, or Erajaya, the establishment of what we know today as the Erajaya Group, was incorporated.
Selengkapnya di halaman ERAA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →